scispace - formally typeset
K

Kumar Dharmarajan

Researcher at Yale University

Publications -  106
Citations -  7667

Kumar Dharmarajan is an academic researcher from Yale University. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 31, co-authored 103 publications receiving 6560 citations. Previous affiliations of Kumar Dharmarajan include Peking Union Medical College & Harvard University.

Papers
More filters
Journal ArticleDOI

Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy

TL;DR: Two genes encode ubiquitin ligases that are potential drug targets for the treatment of muscle atrophy, and mice deficient in either MAFbx orMuRF1 were found to be resistant to atrophy.
Journal ArticleDOI

Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia.

TL;DR: Among Medicare fee-for-service beneficiaries hospitalized for HF, acute MI, or pneumonia, 30-day readmissions were frequent throughout the month after hospitalization and resulted from a similar spectrum of readmission diagnoses regardless of age, sex, race, or time after discharge.
Journal ArticleDOI

Analysis of Machine Learning Techniques for Heart Failure Readmissions

TL;DR: Machine learning methods improved the prediction of readmission after hospitalization for heart failure compared with LR and provided the greatest predictive range in observed readmission rates.
Journal ArticleDOI

Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions.

TL;DR: Readmission rates for patients at hospitals subject to penalties under the HRRP had greater reductions in readmission rates compared with those at nonpenalized hospitals, and changes were greater for target vs nontarget conditions.
Journal ArticleDOI

Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study

TL;DR: Risk declines slowly for older patients after hospitalization for heart failure, acute myocardial infarction, or pneumonia and is increased for months, but knowledge of absolute risks and their changes over time can be used to better align interventions designed to reduce adverse outcomes after discharge with the highest risk periods for patients.